Benitec Biopharma Inc (BNTC)

EBITDA Growth

16.13%

Quarterly · Period ending:

BNTC logo

BNTC EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported16.13%
BNTC Quarterly EBITDA YoY % (-92.97% → 16.13%)
High-resolution chart · PNG

BNTC ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Benitec Biopharma Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
16.1332%
11.5963%
-23.6199%
-69.9123%
-216.8276%
-275.9319%
-59.7735%
1.5884%
-17.8376%
5.7249%
-25.2005%
-16.2585%
8.5102%
-36.3694%
-14.1367%
-0.8094%
-33.0669%
16.904%
-49.8246%
-90.2232%
-33.9879%
-14.2244%
-7.275%
-63.5665%
-34.2836%
-38.9225%
-175.578%
-138.5278%
-1.8476%
-17.8644%
336.9922%
346.0294%
-46.1606%
-45,743.1562%
21.5678%
-361.616%
39.4915%
100.2899%
56.7093%
115.2676%
44.2179%
-9.4346%
-86.4864%
-55.0388%
-133.7895%
20.8604%
-34.5252%
-42.1824%
-165.3756%
-162.3336%
-92.5%
-92.9663%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.